UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Blood, 2007-01, Vol.109 (2), p.478-485

2007

Volltextzugriff (PDF)

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (1), p.26

2002

Volltextzugriff (PDF)

Involvement of Multiple Signaling Pathways in Follicular Lymphoma Transformation: p38-Mitogen-Activated Protein Kinase as a Target for Therapy

Proceedings of the National Academy of Sciences - PNAS, 2003-06, Vol.100 (12), p.7259-7264

2003

Volltextzugriff (PDF)

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation : Results of a phase II trial

Cancer, 2005-10, Vol.104 (8), p.1661-1667

2005

Volltextzugriff (PDF)

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Blood, 2005-11, Vol.106 (10), p.3594-3601

2005

Volltextzugriff (PDF)

Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3

Cell death & disease, 2024-09, Vol.15 (9), p.690-13, Article 690

2024

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases

American journal of clinical pathology, 2003-08, Vol.120 (2), p.246-253

2003

Volltextzugriff (PDF)

TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma

PloS one, 2024-09, Vol.19 (9), p.e0310889

2024

Volltextzugriff (PDF)

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Annals of oncology, 2013-03, Vol.24 (3), p.561-576

2013

Volltextzugriff (PDF)

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

The New England journal of medicine, 2008-08, Vol.359 (6), p.613-626

2008

Volltextzugriff (PDF)

Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas

Bioorganic & medicinal chemistry, 2024-05, Vol.105, p.117725-117725, Article 117725

2024

Volltextzugriff (PDF)

The Current Status and Research Progress of Antiviral Therapy in HCV-Associated Lymphoma --Review

Zhongguo shi yan xue ye xue za zhi, 2021-12, Vol.29 (6), p.1987

2021

Volltextzugriff (PDF)

Comparison of B-Cell Lupus and Lymphoma Using a Novel Immune Imbalance Transcriptomics Algorithm Reveals Potential Therapeutic Targets

Genes, 2024-09, Vol.15 (9), p.1215

2024

Volltextzugriff (PDF)

O6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment

Journal of neuro-oncology, 2012-03, Vol.107 (1), p.147-153

2012

Volltextzugriff (PDF)

TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs

Cell death & disease, 2023-09, Vol.14 (9), p.599-15, Article 599

2023

Volltextzugriff (PDF)

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies

Blood, 2012-05, Vol.119 (22), p.5118-5125

2012

Volltextzugriff (PDF)

Aggressive Lymphomas

The New England journal of medicine, 2010-04, Vol.362 (15), p.1417-1429

2010

Volltextzugriff (PDF)

Pharmacological characteristics and clinical outcomes of Epcoritamab (recombinant) (Epkinly® subcutaneous injection ) for malignant lymphoma

Folia Pharmacologica Japonica, 2024/01/01, Vol.159(1), pp.61-68

2024

Volltextzugriff (PDF)

Disseminated Intravascular B‐Cell Lymphoma: Clinicopathological Features and Outcome of Three Cases Treated with Anthracycline‐Based Immunochemotherapy

The oncologist (Dayton, Ohio), 2006-09, Vol.11 (8), p.923-928

2006

Volltextzugriff (PDF)

Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells

Journal of experimental & clinical cancer research, 2017-02, Vol.36 (1), p.24-24, Article 24

2017

Volltextzugriff (PDF)

Unmittelbare Remission eines mit großzelligem B-Non-Hodgkin-Lymphom befallenen inguinalen Lymphknotens unter alleiniger homöopathischer Behandlung mit Conium: Wann ist eine alleinige adjuvant-homöopathische Tumortherapie zulässig und sinnvoll?

Complementary medicine research, 2019-10, Vol.26 (5), p.361-366

2019

Volltextzugriff (PDF)

Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases

Zhōnghuá zhŏngliú zázhì, 2013-04, Vol.35 (4), p.305

2013

Volltextzugriff (PDF)

1 – 25 von 3.014

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.809)
Mit Volltextzugriff
(1.406)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(2.802)
Male
(1.451)
Female
(1.287)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(1.281)
Middle Aged
(1.088)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(1.022)
Aged
(920)
Adult
(804)
Lymphoma, B-Cell - Drug Therapy
(659)
Cyclophosphamide - Administration & Dosage
(450)
Rituximab
(429)
Lymphoma, Large B-Cell, Diffuse - Pathology
(428)
Vincristine - Administration & Dosage
(417)
Antineoplastic Agents - Therapeutic Use
(409)
Treatment Outcome
(408)
Doxorubicin - Administration & Dosage
(380)
Prognosis
(374)
Cyclophosphamide - Therapeutic Use
(369)
Lymphoma, Non-Hodgkin - Drug Therapy
(363)
Vincristine - Therapeutic Use
(325)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(22)
... seit 90 Tagen
(30)

Menü

Weitere Dienste

Einstellungen

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

Involvement of Multiple Signaling Pathways in Follicular Lymphoma Transformation: p38-Mitogen-Activated Protein Kinase as a Target for Therapy

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation : Results of a phase II trial

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3

Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases

TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas

The Current Status and Research Progress of Antiviral Therapy in HCV-Associated Lymphoma --Review

Comparison of B-Cell Lupus and Lymphoma Using a Novel Immune Imbalance Transcriptomics Algorithm Reveals Potential Therapeutic Targets

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies

MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study

Inhibition of thioredoxin-dependent H 2 O 2 removal sensitizes malignant B-cells to pharmacological ascorbate

O6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment

TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies

Aggressive Lymphomas

Pharmacological characteristics and clinical outcomes of Epcoritamab (recombinant) (Epkinly® subcutaneous injection ) for malignant lymphoma

Disseminated Intravascular B‐Cell Lymphoma: Clinicopathological Features and Outcome of Three Cases Treated with Anthracycline‐Based Immunochemotherapy

Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells

Unmittelbare Remission eines mit großzelligem B-Non-Hodgkin-Lymphom befallenen inguinalen Lymphknotens unter alleiniger homöopathischer Behandlung mit Conium: Wann ist eine alleinige adjuvant-homöopathische Tumortherapie zulässig und sinnvoll?

Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases

Aktive Filter

Suchergebnisse filtern